Andrew Rouse, OD
Optometrist · Miami, FLNPI 1497499875
Payments from drug & device makers
Across 18 payments — averaging $183.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$2K
- Biotissue Holdings Inc.$364
- Bausch & Lomb Americas Inc.$274
- Genentech USA, Inc.$201
- Dompe US, Inc.$150
- Alcon$150
- plus $344 from 4 others
What the payments were for
- Speaking & faculty fees$1,82055%
- Food & beverage$1,48345%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 1 | $1,820 |
| Biotissue Holdings Inc. | 3 | $364 |
| Bausch & Lomb Americas Inc. | 4 | $274 |
| Genentech USA, Inc. | 4 | $201 |
| Dompe US, Inc. | 1 | $150 |
| Alcon | 1 | $150 |
| Sun Pharmaceutical Industries Inc. | 1 | $123 |
| Coopervision Inc. | 1 | $100 |
| Astellas Pharma Global Development | 1 | $93 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CIRRUS HD-OCT$3,640
- CIRRUS AngioPlex$1,820
- CIRRUS 6000 with AngioPlex$1,820
- CIRRUS 5000 with AngioPlex$1,820
- Prokera$254
- AmnioGraft$254
- Oxervate$150
- TRYPTYR$150
- INFUSE$125
- VABYSMO$124
- CEQUA$123
- MiSight Contact Lens$100
How this compares
$3,303 in reported general payments places this provider in the 80th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 18 | $15,434 |
| RhopressaNetarsudil Mesylate | 11 | $7,173 |
| Loteprednol Etabonate | 24 | $2,581 |
| Prednisolone Acetate | 40 | $1,785 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 96 | $947 |
| ValacyclovirValacyclovir Hcl | 35 | $872 |
| Latanoprost | 59 | $473 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 37 | $397 |
| MoxifloxacinMoxifloxacin Hcl | 18 | $389 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 24 | $203 |
| ErythromycinErythromycin Base | 15 | $134 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $70 |
| Azithromycin | 13 | $52 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Miami
- Mark DunbarMiami$236K
- Elise KramerMiami$172K
- Diana ShechtmanMiami$150K
- Angelica CifuentesMiami$68K
- Diana PerezMiami$56K
- Michael KynnJacksonville$4.5M
- Christine HalodaJacksonville$3.1M
- Bradley GieddWinter Park$2.5M
- Christopher PearsonLongwood$2.5M
- Mark PerryOrlando$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.